Log in or Sign up for Free to view tailored content for your specialty!
Cancer Prevention News

AGA stuck in neutral on AI-assisted colonoscopy guidance; ‘close tradeoff’ of cost/benefit
The AGA reported that it could not issue a recommendation for or against the use of computer-aided detection in colonoscopy due to “very low certainty of evidence” and “the close tradeoff between the desirable and undesirable effects.”
Increasing HPV vaccine coverage may decrease cancers among people with HIV

SAN FRANCISCO — Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic Infections.
VIDEO: AI has ‘truly transformational potential’ to detect cancer at most treatable stage

An AI-based cancer prediction system is designed to ensure a higher percentage of cancers are diagnosed at earlier, more treatable stages.
Log in or Sign up for Free to view tailored content for your specialty!
FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide

The FDA released results from its investigation of benzene in acne products containing benzoyl peroxide. In light of these findings, the American Academy of Dermatology updated its statement on benzoyl peroxide in personal care products.
Transportation insecurity greatly reduces adherence to breast cancer screening

Individuals with transportation insecurity appeared 41% less likely to undergo breast cancer screening than those without transportation difficulties, according to results of a cohort study.
ACG unveils gastric premalignancy guidelines aligned with colon, esophagus surveillance

The ACG has released its first guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal metaplasia and dysplasia, in sync with surveillance recommendations established for the colon and esophagus.
Time to vote: Healio | HemOnc Today announce 2025 Disruptive Innovators nominees

Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology.
Cervical precancer incidence falls 80% among women most likely to be vaccinated for HPV

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.
US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’

The U.S. Multi-Society Task Force on Colorectal Cancer has released updated guidance establishing a “reasonable benchmark” for the quality of bowel preparation prior to a colonoscopy exam.
Comorbidities linked to early discontinuation of disease-modifying therapy trials for MS

WEST PALM BEACH, Fla. — A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients with MS who participated in phase 3 clinical trials of disease-modifying therapies, data show.
-
Headline News
Prenatal depression ‘presents differently across cultures,’ warranting tailored care
March 20, 20253 min read -
Headline News
AAD releases measles resource center for dermatologists amid 2025 US outbreaks
March 21, 20253 min read -
Headline News
Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara
March 21, 20252 min read
-
Headline News
Prenatal depression ‘presents differently across cultures,’ warranting tailored care
March 20, 20253 min read -
Headline News
AAD releases measles resource center for dermatologists amid 2025 US outbreaks
March 21, 20253 min read -
Headline News
Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara
March 21, 20252 min read